Fundraising Fox

Metrodora

also invests · investor profile

1 known investors

Metrodora is a venture capital firm that invests in companies working to change how people access care, skills, or information, with a focus on health care startups. Its portfolio includes companies in AI-driven drug development, women's telehealth, and senior care.

Also known as Metrodora Ventures · Metrodora Ventures LLC

Investors · 1

Company profile

researched Aug 2026

Metrodora, operating as Metrodora Ventures LLC, is a venture capital firm that describes itself as values-conscious and invests in the health and learning sectors. It backs companies building products that improve or disintermediate how people access care, skills or information.

Disclosed portfolio companies span senior care technology (Blooming Health, focused on age-friendly technology that connects older adults with friends, family, caregivers and their community), maternity care (Oula, a maternity clinic combining obstetrics and midwifery care), women's health (Teal Health, beginning with cervical cancer screening), digital therapeutics for chronic illness (Swing Therapeutics), AI for drug discovery and development (BioPhy), and care coordination and wraparound services for residents of affordable housing (Ounce).

Business model

Metrodora raises and deploys venture funds, investing capital in early-stage companies in its target sectors and supporting them with market understanding and industry relationships.

Traction

The firm's disclosed portfolio includes Blooming Health, Oula, Teal Health, Swing Therapeutics, BioPhy and Ounce. Press coverage cited by the firm includes BioPhy's $4.5 million AI drug development platform round led by Metrodora and Teal Health's $8.8 million raise for a women's telehealth platform.

Full profile — market position, go-to-market

Market position

The firm is publicly associated with Chelsea Clinton, whose involvement has been referenced in press coverage of its investments in BioPhy and in senior care and caregiving companies.

Go-to-market

Metrodora positions its funds as purpose-built for the earliest stages of company building, pairing capital with sector expertise and industry relationships to help portfolio companies scale.

Founders building companies at the earliest stages within health and learning categories.

Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.

Timeline · 1

launches, deals, and filings
Jan 2024
Metrodora leads $4.5M investment in BioPhy

BioPhy launched an AI platform to accelerate drug development with a $4.5 million investment led by Metrodora, reported by the Philadelphia Business Journal as Chelsea Clinton's VC firm.

$4.5M source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

Research sources · 1

primary sources listed

1 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Metrodora do?
Metrodora is a venture capital firm investing at early stages in health and learning companies.
Who are Metrodora's investors?
Metrodora's investors include Atento Capital.